Fluctuating postdexamethasone cortisol levels in a patient with melancholia.
作者信息
Rothschild A J, Schatzberg A F
出版信息
Am J Psychiatry. 1982 Jan;139(1):129-30. doi: 10.1176/ajp.139.1.129.
PMID:7055259
Abstract
摘要
相似文献
1
Fluctuating postdexamethasone cortisol levels in a patient with melancholia.一名忧郁症患者地塞米松后皮质醇水平波动
Am J Psychiatry. 1982 Jan;139(1):129-30. doi: 10.1176/ajp.139.1.129.
2
Depressive psychomotor disturbance, cortisol, and dexamethasone.
Biol Psychiatry. 1996 Nov 15;40(10):941-50. doi: 10.1016/0006-3223(95)00635-4.
3
A longitudinal study of plasma cortisol and depressive symptomatology by random regression analysis.通过随机回归分析对血浆皮质醇和抑郁症状进行的纵向研究。
Biol Psychiatry. 1992 Feb 1;31(3):304-14. doi: 10.1016/0006-3223(92)90054-4.
4
The dexamethasone suppression test in the clinical setting.临床环境中的地塞米松抑制试验。
Am J Psychiatry. 1983 May;140(5):586-9. doi: 10.1176/ajp.140.5.586.
5
The effect of age on baseline and postdexamethasone cortisol levels in major depressive disorder.年龄对重度抑郁症患者基线及地塞米松治疗后皮质醇水平的影响。
Biol Psychiatry. 1987 Aug;22(8):1029-32. doi: 10.1016/0006-3223(87)90013-8.
6
Correlation between the dexamethasone suppression test in depressed patients and clinical response.抑郁症患者地塞米松抑制试验与临床反应之间的相关性。
Am J Psychiatry. 1984 Feb;141(2):247-9. doi: 10.1176/ajp.141.2.247.
7
Pharmacologic provocation and dexamethasone suppression test sensitivity.药理激发试验和地塞米松抑制试验的敏感性。
Neuropsychobiology. 1989;22(1):11-3. doi: 10.1159/000118585.
8
Postdexamethasone cortisol levels, weight loss, and aging.地塞米松后皮质醇水平、体重减轻与衰老
Biol Psychiatry. 1986 May;21(5-6):575-6. doi: 10.1016/0006-3223(86)90209-x.
9
Postdexamethasone cortisol levels and subgroups of affective illness.地塞米松后皮质醇水平与情感性疾病亚组
Arch Gen Psychiatry. 1985 Jul;42(7):739. doi: 10.1001/archpsyc.1985.01790300107017.
10
Platelet MAO activity and the dexamethasone suppression test in depressed patients.抑郁症患者的血小板单胺氧化酶活性与地塞米松抑制试验
Am J Psychiatry. 1983 Sep;140(9):1231-3. doi: 10.1176/ajp.140.9.1231.
引用本文的文献
1
The dexamethasone suppression test in depressive and schizophrenic patients under controlled treatment conditions.
Eur Arch Psychiatry Neurol Sci. 1986;235(5):263-8. doi: 10.1007/BF00515912.
Zotero 插件